Abstract
Phospholipases A2 (PLA2s) are important enzymes for the metabolism of fatty acids in membrane phospholipids. Among the three major classes of PLA2s in the mammalian system, the group IV calcium-dependent cytosolic PLA2 alpha (cPLA2α) has received the most attention because it is widely expressed in nearly all mammalian cells and its active participation in cell metabolism. Besides Ca2+ binding to its C2 domain, this enzyme can undergo a number of cell-specific post-translational modifications, including phosphorylation by protein kinases, S-nitrosylation through interaction with nitric oxide (NO), as well as interaction with other proteins and lipid molecules. Hydrolysis of phospholipids by cPLA2 yields two important lipid mediators, arachidonic acid (AA) and lysophospholipids. While AA is known to serve as a substrate for cyclooxygenases and lipoxygenases, which are enzymes for the synthesis of eicosanoids and leukotrienes, lysophospholipids are known to possess detergent-like properties capable of altering microdomains of cell membranes. An important feature of cPLA2 is its link to cell surface receptors that stimulate signaling pathways associated with activation of protein kinases and production of reactive oxygen species (ROS). In the central nervous system (CNS), cPLA2 activation has been implicated in neuronal excitation, synaptic secretion, apoptosis, cell-cell interaction, cognitive and behavioral function, oxidative-nitrosative stress, and inflammatory responses that underline the pathogenesis of a number of neurodegenerative diseases. However, the types of extracellular agonists that target intracellular signaling pathways leading to cPLA2 activation among different cell types and under different physiological and pathological conditions have not been investigated in detail. In this review, special emphasis is given to metabolic events linking cPLA2 to activation in neurons, astrocytes, microglial cells, and cerebrovascular cells. Understanding the molecular mechanism(s) for regulation of this enzyme is deemed important in the development of new therapeutic targets for the treatment and prevention of neurodegenerative diseases.
Similar content being viewed by others
Abbreviations
- Aβ:
-
Amyloid beta peptides
- AA:
-
Arachidonic acid
- AACOCF3:
-
Arachidonyl trifluoromethyl ketone
- BEL:
-
Bromoenol lactone
- COX:
-
Cyclooxygenase
- CNS:
-
Central nervous system
- CAMKII:
-
Calcium/calmodulin-dependent protein kinase II
- cPLA2α:
-
Cytosolic phospholipase A2 alpha
- DHA:
-
Docosahexaenoic acid
- ERK1/2:
-
Extracellular signal-regulated kinases 1/2
- IFN-γ:
-
Interferon gamma
- LOX:
-
Lipoxygenase
- LPS:
-
Lipopolysaccharides
- MAFP:
-
Methyl arachidonyl fluorophosphonate
- MAPK:
-
Mitogen-activated protein kinases
- NMDA:
-
N-methyl-d-aspartic acid
- NO:
-
Nitric oxide
- PGE2:
-
Prostaglandin E2
- PKC:
-
Protein kinase C
- PMA:
-
Phorbol myristoyl acetate
- PUFA:
-
Polyunsaturated fatty acids
- ROS:
-
Reactive oxygen species
References
Bazan NG Jr, Rakowski H (1970) Increased levels of brain free fatty acids after electroconvulsive shock. Life Sci 9(9):501–507
Bazan NG Jr (1970) Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta 218(1):1–10
Sun GY, Horrocks LA, Farooqui AA (2007) The roles of NADPH oxidase and phospholipases A2 in oxidative and inflammatory responses in neurodegenerative diseases. J Neurochem 103(1):1–16
Sun GY et al (2010) Phospholipases A2 and inflammatory responses in the central nervous system. Neuromol Med 12(2):133–148
Murakami M et al (2011) Recent progress in phospholipase A(2) research: from cells to animals to humans. Prog Lipid Res 50(2):152–192
Sun GY et al (2012) Integrating cytosolic phospholipase A(2) with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD. Mol Neurobiol 46(1):85–95
Rapoport SI (2013) Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo. Prostaglandins Leukot Essent Fat Acids 88(1):79–85
Cheon Y et al (2012) Disturbed brain phospholipid and docosahexaenoic acid metabolism in calcium-independent phospholipase A(2)-VIA (iPLA(2)beta)-knockout mice. Biochim Biophys Acta 1821(9):1278–1286
Calder PC (2008) The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fat Acids 79(3–5):101–108
Niemoller TD, Bazan NG (2010) Docosahexaenoic acid neurolipidomics. Prostaglandins Other Lipid Mediat 91(3–4):85–89
Eady TN et al (2012) Docosahexaenoic acid signaling modulates cell survival in experimental ischemic stroke penumbra and initiates long-term repair in young and aged rats. PLoS One 7(10):e46151
Palacios-Pelaez R, Lukiw WJ, Bazan NG (2010) Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease. Mol Neurobiol 41(2–3):367–374
Orr SK et al (2013) Unesterified docosahexaenoic acid is protective in neuroinflammation. J Neurochem 127(3):378–393
Mas E et al (2012) Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin Chem 58(10):1476–1484
Linkous A, Yazlovitskaya E (2010) Cytosolic phospholipase A2 as a mediator of disease pathogenesis. Cell Microbiol 12(10):1369–1377
Xu L et al (2008) Activation of cytosolic phospholipase A2alpha through nitric oxide-induced S-nitrosylation. Involvement of inducible nitric-oxide synthase and cyclooxygenase-2. J Biol Chem 283(6):3077–3087
Ward KE et al (2013) The molecular basis of ceramide-1-phosphate recognition by C2 domains. J Lipid Res 54(3):636–648
Nakamura H et al (2013) Lactosylceramide interacts with and activates cytosolic phospholipase A2 alpha. J Biol Chem 288(32):23264–23272
Kalyvas A, David S (2004) Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron 41(3):323–335
Kalyvas A et al (2009) Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis. Brain 132(Pt 5):1221–1235
Kriem B et al (2005) Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide. FASEB J 19(1):85–87
Sanchez-Mejia RO, Mucke L (2010) Phospholipase A2 and arachidonic acid in Alzheimer’s disease. Biochim Biophys Acta 1801(8):784–790
Sanchez-Mejia RO et al (2008) Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer’s disease. Nat Neurosci 11(11):1311–1318
Florent-Bechard S et al (2009) The essential role of lipids in Alzheimer’s disease. Biochimie 91(6):804–809
Gentile MT et al (2012) Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer’s disease pathogenesis. Mol Neurobiol 45(3):596–604
Schaeffer EL, Forlenza OV, Gattaz WF (2009) Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Psychopharmacology (Berl) 202(1–3):37–51
Nakamura H et al (2012) Arachidonic acid metabolism via cytosolic phospholipase A2 alpha induces cytotoxicity in Niemann-Pick disease type C cells. J Cell Physiol 227(7):2847–2855
Linkous AG, Yazlovitskaya EM, Hallahan DE (2010) Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis. J Natl Cancer Inst 102(18):1398–1412
Saluja I et al (1999) Activation of cPLA2, PKC, and ERKs in the rat cerebral cortex during ischemia/reperfusion. Neurochem Res 24(5):669–677
Stephenson D et al (1999) Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration. Glia 27(2):110–128
Bonventre JV et al (1997) Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390(6660):622–625
Moon KH, et al (2014) Phospholipase A2, oxidative stress, and neurodegeneration in binge ethanol-treated organotypic slice cultures of developing rat brain. Alcohol Clin Exp Res 38(1):161–169
Tajuddin NF et al (2013) Effect of repetitive daily ethanol intoxication on adult rat brain: significant changes in phospholipase A2 enzyme levels in association with increased PARP-1 indicate neuroinflammatory pathway activation. Alcohol 47(1):39–45
Rao JS et al (2012) Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J Affect Disord 136(1–2):63–71
Shelat PB et al (2008) Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J Neurochem 106(1):45–55
Brennan AM et al (2009) NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat Neurosci 12(7):857–863
Forlenza OV et al (2007) Inhibition of phospholipase A2 reduces neurite outgrowth and neuronal viability. Prostaglandins Leukot Essent Fat Acids 76(1):47–55
Forlenza OV, Schaeffer EL, Gattaz WF (2007) The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer’s disease. J Neural Transm 114(2):231–238
Tsuda M, Hasegawa S, Inoue K (2007) P2X receptors-mediated cytosolic phospholipase A2 activation in primary afferent sensory neurons contributes to neuropathic pain. J Neurochem 103(4):1408–1416
Hasegawa S et al (2009) Activation of cytosolic phospholipase A2 in dorsal root ganglion neurons by Ca2+/calmodulin-dependent protein kinase II after peripheral nerve injury. Mol Pain 5:22
Pavicevic Z, Leslie CC, Malik KU (2008) cPLA2 phosphorylation at serine-515 and serine-505 is required for arachidonic acid release in vascular smooth muscle cells. J Lipid Res 49(4):724–737
Fatima S et al (2003) CaM kinase IIalpha mediates norepinephrine-induced translocation of cytosolic phospholipase A2 to the nuclear envelope. J Cell Sci 116(Pt 2):353–365
Liu XB, Murray KD (2012) Neuronal excitability and calcium/calmodulin-dependent protein kinase type II: location, location, location. Epilepsia 53(Suppl 1):45–52
Sanford SD et al (2012) Group IVA phospholipase A(2) is necessary for growth cone repulsion and collapse. J Neurochem 120(6):974–984
Qu BX et al (2013) cPLA2alpha knockout mice exhibit abnormalities in the architecture and synapses of cortical neurons. Brain Res 1497:101–105
Antunes G, De Schutter E (2012) A stochastic signaling network mediates the probabilistic induction of cerebellar long-term depression. J Neurosci 32(27):9288–9300
He Y et al (2011) Prolonged exposure of cortical neurons to oligomeric amyloid-beta impairs NMDA receptor function via NADPH oxidase-mediated ROS production: protective effect of green tea (−)-epigallocatechin-3-gallate. ASN Neurol 3(1):e00050
Malaplate-Armand C et al (2006) Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. Neurobiol Dis 23(1):178–189
Sagy-Bross C, Hadad N, Levy R (2013) Cytosolic phospholipase Aalpha upregulation mediates apoptotic neuronal death induced by aggregated amyloid-beta peptide. Neurochem Int 63(6):541–550
Desbene C et al (2012) Critical role of cPLA2 in Abeta oligomer-induced neurodegeneration and memory deficit. Neurobiol Aging 33(6):1123.e17–29
Chalimoniuk M et al (2009) Involvement of multiple protein kinases in cPLA2 phosphorylation, arachidonic acid release, and cell death in in vivo and in vitro models of 1-methyl-4-phenylpyridinium-induced parkinsonism—the possible key role of PKG. J Neurochem 110(1):307–317
Last V, Williams A, Werling D (2012) Inhibition of cytosolic phospholipase A2 prevents prion peptide-induced neuronal damage and co-localisation with beta III tubulin. BMC Neurosci 13:106
Sundaram JR et al (2012) Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration. J Neurosci 32(3):1020–1034
Fang XX et al (2013) Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways. Cell Mol Neurobiol 33(2):241–251
Kishimoto K et al (2010) Cytosolic phospholipase A2 alpha amplifies early cyclooxygenase-2 expression, oxidative stress and MAP kinase phosphorylation after cerebral ischemia in mice. J Neuroinflammation 7:42
Xu J et al (2002) Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes. J Neurochem 83(2):259–270
Xu J et al (2003) Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukot Essent Fat Acids 69(6):437–448
Xiang Y et al (2013) Inhibition of sPLA2-IIA prevents LPS-induced neuroinflammation by suppressing ERK1/2-cPLA2alpha pathway in mice cerebral cortex. PLoS One 8(10):e77909
Norenberg MD, Rama Rao KV, Jayakumar AR (2009) Signaling factors in the mechanism of ammonia neurotoxicity. Metab Brain Dis 24(1):103–117
Floreani NA et al (2010) Alcohol-induced interactive phosphorylation of Src and toll-like receptor regulates the secretion of inflammatory mediators by human astrocytes. J Neuroimmune Pharm 5(4):533–545
Prasad VV, Nithipatikom K, Harder DR (2008) Ceramide elevates 12-hydroxyeicosatetraenoic acid levels and upregulates 12-lipoxygenase in rat primary hippocampal cell cultures containing predominantly astrocytes. Neurochem Int 53(6–8):220–229
Hsieh HL et al (2007) BK-induced COX-2 expression via PKC-delta-dependent activation of p42/p44 MAPK and NF-kappaB in astrocytes. Cell Signal 19(2):330–340
Hsieh HL et al (2006) BK-induced cytosolic phospholipase A2 expression via sequential PKC-delta, p42/p44 MAPK, and NF-kappaB activation in rat brain astrocytes. J Cell Physiol 206(1):246–254
Liao SL et al (2013) Diethylmaleate and iodoacetate in combination caused profound cell death in astrocytes. J Neurochem 127(2):271–282
Zhu D et al (2006) Phospholipases A2 mediate amyloid-beta peptide-induced mitochondrial dysfunction. J Neurosci 26(43):11111–11119
Zhu D et al (2009) NAD(P)H oxidase-mediated reactive oxygen species production alters astrocyte membrane molecular order via phospholipase A2. Biochem J 421(2):201–210
Akundi RS et al (2005) Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia. Glia 51(3):199–208
Anrather J et al (2011) Purinergic signaling induces cyclooxygenase-1-dependent prostanoid synthesis in microglia: roles in the outcome of excitotoxic brain injury. PLoS One 6(10):e25916
Suram S et al (2013) Cytosolic phospholipase A(2)alpha and eicosanoids regulate expression of genes in macrophages involved in host defense and inflammation. PLoS One 8(7):e69002
Kellom M et al (2012) Dose-dependent changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammation. BMC Neurosci 13:50
Sheng W et al (2011) Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA(2)-IIA expression in astrocytes and microglia. J Neuroinflammation 8:121
Chuang DY et al (2013) Magnolia polyphenols attenuate oxidative and inflammatory responses in neurons and microglial cells. J Neuroinflammation 10:15
Ribeiro R et al (2013) Involvement of ERK1/2, cPLA2 and NF-kappaB in microglia suppression by cannabinoid receptor agonists and antagonists. Prostaglandins Other Lipid Mediat 100–101:1–14
Vana AC et al (2011) Arachidonyl trifluoromethyl ketone ameliorates experimental autoimmune encephalomyelitis via blocking peroxynitrite formation in mouse spinal cord white matter. Exp Neurol 231(1):45–55
Shibata N et al (2011) 4-Hydroxy-2-nonenal upregulates and phosphorylates cytosolic phospholipase A(2) in cultured Ra2 microglial cells via MAPK pathways. Neuropathology 31(2):122–128
Szaingurten-Solodkin I, Hadad N, Levy R (2009) Regulatory role of cytosolic phospholipase A2alpha in NADPH oxidase activity and in inducible nitric oxide synthase induction by aggregated Abeta1-42 in microglia. Glia 57(16):1727–1740
Gao J et al (1997) An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. J Biol Chem 272(2):1226–1230
Ji RR, Suter MR (2007) p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 3:33
Matsui T et al (2010) Release of prostaglandin E(2) and nitric oxide from spinal microglia is dependent on activation of p38 mitogen-activated protein kinase. Anesth Analg 111(2):554–560
Ma L, Nagai J, Ueda H (2010) Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain. J Neurochem 115(3):643–653
Ma L et al (2013) An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model. Mol Pain 9(1):29
Alberghina M (2010) Phospholipase A(2): new lessons from endothelial cells. Microvasc Res 80(2):280–285
Askarova S et al (2011) Role of Abeta-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A(2) activation in astrocytes and cerebral endothelial cells. Neuroscience 199:375–385
Zhang Q et al (2011) Activation of cytosolic phospholipase A2 downstream of the Src-phospholipase D1 (PLD1)-protein kinase C gamma (PKCgamma) signaling axis is required for hypoxia-induced pathological retinal angiogenesis. J Biol Chem 286(25):22489–22498
Anfuso CD et al (2007) Endothelial cell-pericyte cocultures induce PLA2 protein expression through activation of PKCalpha and the MAPK/ERK cascade. J Lipid Res 48(4):782–793
Salmeri M et al (2012) Involvement of PKCalpha-MAPK/ERK-phospholipase A(2) pathway in the Escherichia coli invasion of brain microvascular endothelial cells. Neurosci Lett 511(1):33–37
Maruvada R et al (2011) Host cytosolic phospholipase A(2)alpha contributes to group B Streptococcus penetration of the blood-brain barrier. Infect Immun 79(10):4088–4093
Li Q et al (2010) PI3K-dependent host cell actin rearrangements are required for Cronobacter sakazakii invasion of human brain microvascular endothelial cells. Med Microbiol Immunol 199(4):333–340
Nito C et al (2008) Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 28(10):1686–1696
Zhang J et al (2012) Inhibition of cytosolic phospholipase A(2) alpha protects against focal ischemic brain damage in mice. Brain Res 1471:129–137
Spencer JP et al (2012) Neuroinflammation: modulation by flavonoids and mechanisms of action. Mol Aspects Med 33(1):83–97
Defillipo PP et al (2012) Inhibition of cPLA2 and sPLA2 activities in primary cultures of rat cortical neurons by Centella asiatica water extract. Nat Prod Commun 7(7):841–843
Zhao Z et al (2011) Inhibition of cPLA2 activation by Ginkgo biloba extract protects spinal cord neurons from glutamate excitotoxicity and oxidative stress-induced cell death. J Neurochem 116(6):1057–1065
Oh WJ et al (2013) Inhibition of lipopolysaccharide-induced proinflammatory responses by Buddleja officinalis extract in BV-2 microglial cells via negative regulation of NF-kB and ERK1/2 signaling. Molecules 18(8):9195–9206
Yeh CH, et al (2013) Wogonin attenuates endotoxin-induced prostaglandin E2 and nitric oxide production via Src-ERK1/2-NFkappaB pathway in BV-2 microglial cells. Toxicol Ind Health doi:10.1177/0748233713485886
Subramaniam S, Unsicker K (2010) ERK and cell death: ERK1/2 in neuronal death. FEBS J 277(1):22–29
Acknowledgments
This work was supported in part by NIH Grants 2P01 AG08357 from the NIA and P50AT006273 from the National Center for Complementary and Alternative Medicines (NCCAM), the Office of Dietary Supplements (ODS), and the National Cancer Institute (NCI). The help of Ms. Deborah Ratliff to proofread and edit the manuscript is much appreciated.
Conflict of Interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sun, G.Y., Chuang, D.Y., Zong, Y. et al. Role of Cytosolic Phospholipase A2 in Oxidative and Inflammatory Signaling Pathways in Different Cell Types in the Central Nervous System. Mol Neurobiol 50, 6–14 (2014). https://doi.org/10.1007/s12035-014-8662-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-014-8662-4